Erectile DysfunctionSulfonesPenile ErectionPurinesImpotence, VasculogenicPenisPhosphodiesterase 5 InhibitorsPhosphodiesterase InhibitorsPiperazinesPenile ProsthesisCyclic Nucleotide Phosphodiesterases, Type 5CarbolinesPenile ImplantationPriapism3',5'-Cyclic-GMP PhosphodiesterasesVasodilator AgentsAlprostadilTriazinesLibidoSexual Dysfunctions, PsychologicalSexual Dysfunction, PhysiologicalPenile IndurationUrological AgentsPapaverineCoitusErgoloid MesylatesEjaculationSex CounselingTreatment OutcomeUrologic DiseasesTestosteroneButeaVentricular Dysfunction, LeftCyclic GMPHypogonadismDouble-Blind MethodHypertension, PulmonaryEpimediumInjectionsOrgasmUrethraNitric OxidePatient SatisfactionAdministration, OralVacuumPyrimidinonesCross-Over StudiesPhentolamineImidazolesSet (Psychology)PrevalenceProstatectomyPremature EjaculationRisk FactorsTribulusQatarPenile DiseasesPhosphoric Diester HydrolasesDose-Response Relationship, DrugQuestionnairesEndothelium, VascularApomorphineUrination DisordersSeverity of Illness IndexCarthamusDisease Models, AnimalCynomoriumDoxazosinTime FactorsPlacebosNitric Oxide Synthase Type IMen's HealthBlood PressureAdrenergic alpha-AntagonistsRats, Sprague-DawleyMuscle, SmoothLepidiumVasodilationProstatismCardiovascular DiseasesUrinary IncontinenceNitric Oxide Synthase Type IIIProspective StudiesDiabetes ComplicationsNitric Oxide Synthase